Protalix Biotherapeutics Inc (PLX) — Free Cash Flow Generation Index
Protalix Biotherapeutics Inc (PLX) has a Free Cash Flow Generation Index of 1.61x as of December 2025. Free cash flow of $3.27 Million represents 2% of operating cash flow ($2.03 Million). Read total liabilities of Protalix Biotherapeutics Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Protalix Biotherapeutics Inc Free Cash Flow Generation Index (2009–2024)
Historical FCF Generation Index trend for Protalix Biotherapeutics Inc across 3 annual periods. Explore reinvestment intensity of Protalix Biotherapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Protalix Biotherapeutics Inc (2009–2024)
Year-by-year Free Cash Flow Generation Index for Protalix Biotherapeutics Inc. For the full company profile including market capitalisation, see market value of Protalix Biotherapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.85x | $7.39 Million | $8.67 Million | $1.28 Million | ▲ +137.8% |
| 2012 | -2.26x | $-1.43 Million | $635.00K | $2.07 Million | ▼ -362.2% |
| 2009 | 0.86x | $38.26 Million | $44.45 Million | $6.20 Million | — |